Status:
RECRUITING
Impact of Surgical Injury on Haemostatic Tests in Patients Undergoing Total Hip Replacement With Subgroup Analysis of Patients With Neoplasm
Lead Sponsor:
Medical University of Warsaw
Conditions:
Total Hip Replacement
Thromboelastometry
Eligibility:
All Genders
18+ years
Brief Summary
Total hip replacement (THR) is associated with extensive tissue injury and considerable blood loss that can be complicated by hyperfibrinolysis with an increased need for blood transfusion. THR in pat...
Eligibility Criteria
Inclusion
- Adult patients undergoing primary elective total hip replacement
Exclusion
- Patients unable to consent to trial
- Active deep and superficial vein thrombosis
- Coagulopathy in initial coagulation screen tests
- Platelet count below 100 thousand
- Patients on antithrombotic medications (except prophylactic low molecular weight heparins and acetylsalicylic acid up to 75 mg per day)
- Preoperative haemoglobin \< 10 g/dl
- Female patients who are pregnant or nursing
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04442373
Start Date
January 1 2020
End Date
December 31 2024
Last Update
January 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
I Department of Anesthesiology and Intensive Care Warsaw Medical University
Warsaw, Masovian Voivodeship, Poland, 02-005